-
Je něco špatně v tomto záznamu ?
Muscarinic M2 receptors directly activate Gq/11 and Gs G-proteins
Michal P, El-Fakahany EE, Dolezal V.
Jazyk angličtina Země Spojené státy americké
NLK
Open Access Digital Library
od 1997-01-01 do Před 1 rokem
ASPET Journals
od 1997 do 2013
- MeSH
- AMP cyklický biosyntéza MeSH
- CHO buňky MeSH
- Cricetulus MeSH
- financování organizované MeSH
- inositolfosfáty metabolismus MeSH
- křečci praví MeSH
- malá interferující RNA farmakologie MeSH
- proteiny vázající GTP - alfa-podjednotky Gq-G11 fyziologie MeSH
- proteiny vázající GTP - alfa-podjednotky Gs fyziologie MeSH
- receptor muskarinový M2 fyziologie MeSH
- zvířata MeSH
- Check Tag
- křečci praví MeSH
- zvířata MeSH
Muscarinic M(2) receptors preferentially couple with the G(i/o) class of G-proteins to inhibit cAMP synthesis. However, they can also stimulate net synthesis of cAMP and inositol phosphate (IP) accumulation. We investigated in intact Chinese hamster ovary (CHO) cells expressing human M(2) receptors (CHO-M(2) cells) whether direct interaction of M(2) receptors with G(s) and G(q/11) G-proteins is responsible for the latter effects. Suppression of the G(s)alpha subunit using RNA interference abolished stimulation of cAMP synthesis induced by 1 mM carbachol in both control and pertussis toxin-treated CHO-M(2) cells but had no effect on the inhibition of forskolin-stimulated cAMP synthesis. Carbachol stimulated accumulation of IP with an EC(50) of 79 microM. Removal of the G(q),G(11), or both alpha subunits reduced this response by 78, 54, and 92%, respectively, whereas suppression of the G(s)alpha subunit had no effect. Similar results obtained in CHO cells expressing M(1) receptors that preferentially couple with G(s) and G(q/11) G-proteins confirmed the efficiency of siRNA treatments. Stimulation of M(2) receptors in control and pertussis toxin-treated cells by a series of full agonists with respect to inhibition of adenylyl cyclase displayed different efficacies in stimulating IP accumulation. Carbachol, acetylcholine, and oxotremorine-M [N,N,N-trimethyl-4-(2-oxo-1-pyrolidinyl)-2-butyn-1-ammonium] behaved as full agonists, furmethide (N,N,N-trimethyl-2-furanmethammonium) and methylfurmethide [(5-methyl-2-furyl)methyltrimethylammonium] were partial agonists, and oxotremorine (1-[4-(1-pyrrolidinyl)-2-butynyl]-2-pyrrolidinone) had no effect. Our results provide direct evidence of M(2) receptor coupling with the alpha subunits of G(s) and G(q/11) G-proteins and demonstrate induction of multiple receptor conformational states dependent on both the concentration and the nature of the agonist used.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc09003906
- 003
- CZ-PrNML
- 005
- 20200313100657.0
- 008
- 091125s2007 xxu e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Michal, Pavel. $7 _BN002852
- 245 10
- $a Muscarinic M2 receptors directly activate Gq/11 and Gs G-proteins / $c Michal P, El-Fakahany EE, Dolezal V.
- 314 __
- $a Institute of Physiology CAS, Vídenská 1083, 14220 Prague, Czech Republic
- 520 9_
- $a Muscarinic M(2) receptors preferentially couple with the G(i/o) class of G-proteins to inhibit cAMP synthesis. However, they can also stimulate net synthesis of cAMP and inositol phosphate (IP) accumulation. We investigated in intact Chinese hamster ovary (CHO) cells expressing human M(2) receptors (CHO-M(2) cells) whether direct interaction of M(2) receptors with G(s) and G(q/11) G-proteins is responsible for the latter effects. Suppression of the G(s)alpha subunit using RNA interference abolished stimulation of cAMP synthesis induced by 1 mM carbachol in both control and pertussis toxin-treated CHO-M(2) cells but had no effect on the inhibition of forskolin-stimulated cAMP synthesis. Carbachol stimulated accumulation of IP with an EC(50) of 79 microM. Removal of the G(q),G(11), or both alpha subunits reduced this response by 78, 54, and 92%, respectively, whereas suppression of the G(s)alpha subunit had no effect. Similar results obtained in CHO cells expressing M(1) receptors that preferentially couple with G(s) and G(q/11) G-proteins confirmed the efficiency of siRNA treatments. Stimulation of M(2) receptors in control and pertussis toxin-treated cells by a series of full agonists with respect to inhibition of adenylyl cyclase displayed different efficacies in stimulating IP accumulation. Carbachol, acetylcholine, and oxotremorine-M [N,N,N-trimethyl-4-(2-oxo-1-pyrolidinyl)-2-butyn-1-ammonium] behaved as full agonists, furmethide (N,N,N-trimethyl-2-furanmethammonium) and methylfurmethide [(5-methyl-2-furyl)methyltrimethylammonium] were partial agonists, and oxotremorine (1-[4-(1-pyrrolidinyl)-2-butynyl]-2-pyrrolidinone) had no effect. Our results provide direct evidence of M(2) receptor coupling with the alpha subunits of G(s) and G(q/11) G-proteins and demonstrate induction of multiple receptor conformational states dependent on both the concentration and the nature of the agonist used.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a CHO buňky $7 D016466
- 650 _2
- $a křečci praví $7 D006224
- 650 _2
- $a Cricetulus $7 D003412
- 650 _2
- $a AMP cyklický $x biosyntéza $7 D000242
- 650 _2
- $a proteiny vázající GTP - alfa-podjednotky Gq-G11 $x fyziologie $7 D043802
- 650 _2
- $a proteiny vázající GTP - alfa-podjednotky Gs $x fyziologie $7 D019205
- 650 _2
- $a inositolfosfáty $x metabolismus $7 D007295
- 650 _2
- $a malá interferující RNA $x farmakologie $7 D034741
- 650 _2
- $a receptor muskarinový M2 $x fyziologie $7 D043585
- 700 1_
- $a El-Fakahany, Esam E. $7 xx0067696
- 700 1_
- $a Doležal, Vladimír, $d 1952 červen 12.- $7 nlk19990073099
- 773 0_
- $w MED00002900 $t The journal of pharmacology and experimental therapeutics $g Roč. 320, č. 2 (2007), s. 607-614 $x 0022-3565
- 910 __
- $a ABA008 $b x $y 8 $z 0
- 990 __
- $a 20091123115031 $b ABA008
- 991 __
- $a 20200313101117 $b ABA008
- 999 __
- $a ok $b bmc $g 699724 $s 562136
- BAS __
- $a 3
- BMC __
- $a 2007 $b 320 $c 2 $d 607-614 $i 0022-3565 $m The Journal of pharmacology and experimental therapeutics $x MED00002900
- LZP __
- $a 2009-B3/dkme